Danilo Cimadomo is the Science and Research Manager of the GeneraLife IVF. He received BSc and MSc degrees cum laude at the University of Pavia in “Medical Biotechnologies” and “Molecular Biology and Genetics”, respectively, an advanced course in "Novel technologies in molecular medicine" at the University of Padua, and a Ph.D. at the University of Rome “Sapienza” in “Morphogenesis and Tissue Engineering”. After two internships at the University of Pavia and at the University of Cambridge (UK), he started working at the GENERA centers in Italy where he contributed to the validation, implementation and monitoring of a blastocyst stage-based aneuploidy testing program for PGT. His research is focused on the strategies to outline embryo competence and on their clinical application. He is reviewer or associate editor for several international journals in the field of reproductive medicine, member of the executive committee of SIERR (Italian society of embryology, research and reproduction), member of the ESHRE (European society of human reproduction and embryology) working group that updated the guidelines for human embryo biopsy, and basic science officer of the ESHRE special interest group (SIG) in “implantation and early pregnancy”. He is Author or co-Author of more than 60 papers in peer-reviewed journals and book chapters, along with several abstracts at Italian and international meetings.